Cardiovascular Outcomes in Bariatric Surgery Patients With Type 2 Diabetes
| 対象疾患 | Obesity, Type2 Diabetes, Bariatric Surgery Candidate |
|---|---|
| 相 | 該当なし |
| スポンサー | The Cleveland Clinic |
| ステータス | 完了 |
| 参加者数 | 91,700 名 |
| 介入（薬剤） | Bariatric Surgery |
| 開始日 | 2019年6月5日 |
| 完了日 | 2019年7月12日 |
| 結果公開日 | 2026年8月3日 |
概要
The objective of the analysis was to evaluate the relationship between bariatric surgery and cardiovascular outcomes in obese patients with type 2 diabetes.
All-Cause Mortality and/or Cardiovascular Outcomes
| Bariatric Surgery | 30.8 percentage of participants |
|---|---|
| Non-Surgical Control | 47.7 percentage of participants |
BENITIONS で見る ClinicalTrials.gov の原文を見る
同じ疾患の他の治験
- Diabetes Prevention Program Outcomes Study — National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Uric Acid Lowering Trial in Youth Onset T2D — University of Colorado, Denver
- Financial Incentives And Nurse Coaching to Enhance Diabetes Outcomes (FINANCE-DM)-1 — State University of New York at Buffalo
- Continuous Glucose Monitoring Following Hospital Discharge — Kathleen Dungan
- Skeletal Muscle Diacylglycerol and Sphingolipids - Impact of Localization and Species on I — University of Colorado, Denver
- A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus — Eli Lilly and Company